Security key
89422GAA5
- Security type / class
- Debt / NOTE 2.250% 3/0
- Reported market price (% of par)
- 126.25%
- Total 13F principal
- $317,235,000
- Principal change
- +$503,000
- Total reported market value
- $401,223,699
- Number of holders
- 27
- Value change
- -$5,435,851
- Number of buys
- 16
- Number of sells
- 17
Security identity
Holder snapshot
Report period
Q1 2026
Institutions
27
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 89422GAA5
Recent filing periods:
Ownership snapshot
Top shareholders of 89422GAA5 - TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
—
13D/G signal
—
Evidence rows
0
Latest as of
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Principal
$317,235,000
Rows loaded
27
| Investor | Option | Weight % | Change % | Reported value | * Price (% of par) | Principal | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
33
Q1 2026 holders
27
Holder diff
-6
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend